Evoke Pharma, Inc. (EVOK)
Dec 17, 2025 - EVOK was delisted (reason: acquired by QOL Medical)
11.00
+0.04 (0.36%)
Inactive · Last trade price
on Dec 16, 2025
Evoke Pharma Employees
Evoke Pharma had 3 employees as of December 31, 2024. The number of employees decreased by 1 or -25.00% compared to the previous year.
Employees
3
Change (1Y)
-1
Growth (1Y)
-25.00%
Revenue / Employee
$4,808,217
Profits / Employee
-$1,742,043
Market Cap
23.72M
Employees Chart
EVOK News
- 2 months ago - Evoke Pharma and QOL Medical Announce Expiration of Tender Offer - PRNewsWire
- 3 months ago - Evoke assesses Italian unit sale amid tax concerns ahead of budget, Sky News reports - Reuters
- 4 months ago - MAI Capital Management Announces Expanded Office of Managing Partners Appointments Following Strategic Acquisition of Evoke Advisors - Business Wire
- 5 months ago - Evoke Advisors Ranked No. 1 on Forbes' ‘America's Top RIA Firms' List for Fourth Consecutive Year - Business Wire
- 6 months ago - MAI Capital Management Announces Strategic Partnership with Evoke Advisors - Business Wire
- 6 months ago - Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship - GlobeNewsWire
- 7 months ago - Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book - GlobeNewsWire
- 7 months ago - Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038 - GlobeNewsWire